Carl Decicco - Net Worth and Insider Trading
Carl Decicco Net Worth
The estimated net worth of Carl Decicco is at least $2 Million dollars as of 2024-06-07. Carl Decicco is the Chief Scientific Officer of Foghorn Therapeutics Inc and owns about 258,397 shares of Foghorn Therapeutics Inc (FHTX) stock worth over $2 Million. Details can be seen in Carl Decicco's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Carl Decicco has not made any transactions after 2020-10-27 and currently still holds the listed stock(s).
Transaction Summary of Carl Decicco
Carl Decicco Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Carl Decicco owns 1 companies in total, including Foghorn Therapeutics Inc (FHTX) .
Click here to see the complete history of Carl Decicco’s form 4 insider trades.
Insider Ownership Summary of Carl Decicco
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-27 | Chief Scientific Officer |
Carl Decicco Latest Holdings Summary
Carl Decicco currently owns a total of 1 stock. Carl Decicco owns 258,397 shares of Foghorn Therapeutics Inc (FHTX) as of October 27, 2020, with a value of $2 Million.
Latest Holdings of Carl Decicco
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-27 | 258,397 | 5.99 | 1,547,798 |
Holding Weightings of Carl Decicco
Carl Decicco Form 4 Trading Tracker
According to the SEC Form 4 filings, Carl Decicco has made a total of 1 transactions in Foghorn Therapeutics Inc (FHTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Foghorn Therapeutics Inc is the acquisition of 5,500 shares on October 27, 2020, which cost Carl Decicco around $88,000.
Insider Trading History of Carl Decicco
- 1
Carl Decicco Trading Performance
GuruFocus tracks the stock performance after each of Carl Decicco's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Carl Decicco is 8.94%. GuruFocus also compares Carl Decicco's trading performance to market benchmark return within the same time period. The performance of stocks bought by Carl Decicco within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Carl Decicco's insider trading performs compared to the benchmark.
Performance of Carl Decicco
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30.94 | | | | | |
| Relative Return to S&P 500(%) | 23.64 | | | | | |
Carl Decicco Ownership Network
Carl Decicco Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Carl Decicco is the Chief Scientific Officer of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief Strategy/Bus Ops Officer Fanny Cavalie , Chief Medical Officer Alfonso Quintas Cardama , and Chief Medical Officer Samuel Agresta .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Carl Decicco made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 11,000 shares made by Fanny Cavalie .
In summary, during the past 3 months, insiders sold 11,000 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 11,000 shares. During the past 18 months, 322,297 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 322,297 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Carl Decicco Mailing Address
Above is the net worth, insider trading, and ownership report for Carl Decicco. You might contact Carl Decicco via mailing address: 100 Binney Street, Suite 610, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
